Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-377-0 | CAS number: 811-97-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: EPA Guideline, In vivo mammalian bone marrow cytogenetic tests: micronucleus assay. HG. - Chromo-Micronuc, August 1982.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Norflurane
- EC Number:
- 212-377-0
- EC Name:
- Norflurane
- Cas Number:
- 811-97-2
- Molecular formula:
- C2H2F4
- IUPAC Name:
- 1,1,1,2-tetrafluoroethane
- Details on test material:
- - Name of test material (as cited in study report): 1,1,1,2-tetrafluoroethane
- Substance type: pure active substance
- Physical state: colourless gas at room temperature
- Analytical purity: >98.3% according to specification.
- Impurities (identity and concentrations): Toxicology test grade specification defined by joint panel 10-20-1987
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: HOECHST AG, Kastengrund, SPF breeding colony
- Age at study initiation: 7 weeks
- Weight at study initiation: males mean: 28.0g (25 - 30 g); females mean: 23.0g (21 - 37g)
- Assigned to test groups randomly: [no/yes, under following basis: ]
- Fasting period before study:
- Housing: in fully air-conditioned rooms in Macrolon cages (Type 3), on softwood granulate in groups of 5 animals
- Diet (e.g. ad libitum): ad libitum - rat/mice diet Altromin 1324 (Altromin-GmbH, Lage/Lippe)
- Water (e.g. ad libitum): ad libitum - tap water in plastic bottles
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 55 ± 10
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12 hours light / 12 hours darkness
IN-LIFE DATES: From: To:
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- none
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: nose only
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Stainless steel and glass cylinder with a volume of 80 litres, standing in a vent pipe with a volume of approximately 4m3.
- Method of holding animals in test chamber: placed individually in cylindrical plastic tubes.
- Source and rate of air: 800 litres / hour
- Method of conditioning air: oxygen was added as necessary to prevent anoxia
- Treatment of exhaust air: drawn off and neutralised by gas-cleaning equipment
TEST ATMOSPHERE
- Brief description of analytical method used: every 30 minutes using a single beam photometer (Foxboro Analytical, South Northwalk, USA)
- Samples taken from breathing zone: yes - Duration of treatment / exposure:
- 6 hours. In the highest dose level (50000ppm) the inhalation period of the females was only 5 hours due to low supplies of test substance.
- Frequency of treatment:
- single exposure
- Post exposure period:
- Animals were terminated 24, 48 or 72 hours after treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 50000, 150000, 500000 ppm
Basis:
nominal conc.
see table A for measured mean concentrations.
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- yes, concurrent no treatment
- Positive control(s):
- cyclophosphamide - Endoxan®
- Justification for choice of positive control(s):
- Route of administration: inhalation (nose only)
- Doses / concentrations: 2.5 hours (2.5 mg/l air)
Examinations
- Tissues and cell types examined:
- Bone marrow, erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The dose levels were selected on the basis of acute toxicity studies, which yielded a 4 hour LC 50 greater than 50 vol % in rats. Therefore a top dose of 50 vol % HFC 134a was chosen.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
DETAILS OF SLIDE PREPARATION: In conformity with the test procedure the animals were killed by carbon dioxide asphyxiation 24, 48 or 72 hours after the end of the inhalation period. For each animal, about 3ml foetal bovine serum was poured into a centrifuge tube. Both femora were removed and the bones freed of muscle tissue. Teh proximal ends of the femora were opened and the bone marrow flushed into the centrifuge tube. A suspension was formed. The mixture was then centrifuged for 5 minutes at 1200 rpm and almost all the supernatant discarded. On drop of the thoroughly mixed sediment was smeared on a cleaned slide, identified by project code and animal number, and air dried for about 24 hours.
Staining procedure:
- 5 minutes in methanol
- 3 minutes in May-Grünwalds solution
- 2 minutes in May-Grünwalds solution diluted 1:1 with distilled water
- brief rinsing twice in distilled water
-10 minutes staining in 1 part Giesma solution to 6 parts buffer solution, pH 7.2 (Weise)
- rinsing in distilled water
- drying
- coating with Entellen (rapid mounting media for microscopy)
METHOD OF ANALYSIS:
OTHER: - Evaluation criteria:
- One thousand polychromatic erythrocytes were counted for each animal. The number of cells with micronuclei was recorded, not the number of individual micronuclei. As a control measure 1000 mature erythrocytes were also counted and examined for micronuclei. In addition, the ratio of polychromatic to normochromatic erythrocytes was determined. All bone marrow smears for evaluation were coded to ensure that the group to which they belonged was unknown to the investigator. The number of polychromatic erythrocytes with micronuclei occuring in the 1000 polychromatic erythrocytes counted, and the number of normocytes with micronuclei occuring in the 1000 normocytes counted, were evaluated statistically; comparison of dose groups with the simultaneous control group was performed according to Wilcoxon ( paired, one sided increase).
The results of the treatment groups (test substance) in the micronucleus test at each dose and sacrifice interval were compared with corresponding control values. The ratio of polychromatic to normochromatic erythrocytes was also evaluated statistically by the method of Wilcoxon (paired, two sided). - Statistics:
- The statistical evaluations were performed using the "Diamant" computer program version 2.0, supplied by the Department of Information and Communication Hoechst AG. All statistical results are based on a 95% level of significance. Actual data were also compared with historical controls.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- 5.0 vol % - increased spontaneous activity, irregular breathing; 15.0 vol % - increased spontaneous activity, irregular breathing; 50.0 vol % - increased spontaneous activity, irregular breathing, ataxic gait, reduced pawreflex to pinching, reduced placin
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
The bone marrow smears were examined for the occurance of micronuclei in red blood cells. The incidence of micronucleated polychromatic erythrocytes in the dose groups of HFC 134a was within the range of the negative control groups. No statistically significant increase of micronucleated polychromatic erythrocytes was observed. The number of normochromatic erythrocytes with micornuclei did not differ significantly from the values of the simultaneous control animals for each of the three sacrifice intervals investigated. The ratio of polychromatic erythrocytes remained essentially unaffected by the test compound.
Treatment with Cyclophosphamide (Endoxan®) for 2.5 hours induced a marked and statistically significant increase in the number of polychromatic erythrocytes with micronuclei in both males and females indicating the sensitivity of the test system.
The test ws performed according to the methods described. No unforseen circumstances were observed which may have affected the the quality and integrity of the the study.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
In a micronucleus assay, NMRI mice were exposure for 6 hours to concentrations of up to 500000ppm HFC 134a. The incidence of micronucleated polychromatic erythrocytes in the bone marrow was not statistically significantly different from controls. The ratio of poly- to normo-chromatic cells remained unaffected by the treatment with HFC 134a. HFC 134 was therefore demonstrated to be not mutagenic in the micronucleus test. - Executive summary:
HFC 134a was tested in the micronucleus test. The test compound was administered in a single inhalation period to male and female NMRI mice. The following doses were tested: 0, 5.0, 15.0 and 50.0% vol/vol.
Single acute toxicity studies yielded a 4 -hour L50 greater than 50% v/v HFC 134a and this concentration was chosen the top dose level.
The animals were treated over an exposure period of 6 hours with the test compound and according to the test procedure the animals were killed 24, 48 or 72 hours after inhalation. In the highest dose level the inhalation period of the females was only 5 hours instead of 6 hours due low substance resources.
Endoxan® was used as a positive control substance and was administered in a single inhalation period over 2.5 hours (2.5 mg/l) in air.
The incidence of micronucleated polychromatic erythrocytes in the animals treated with HFC 134a was within the normal range of negative control. The number of normochromatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic/normochromatic erythrocytes in both male and female animals remained unaffected by treatment with HFC 134a and was statsically not changed from control values.
Endoxan® induced in both males and females a marked statistically significant increase in the number of polychromatic cells with micronuclei, confirming the sensitivity of the system. The ratio of polychromatic erythrocytes to normocytes was not changed to any significant extent.
The results show that, under the conditions of the study, HFC 134a is not mutagenic in the micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.